SCOPUS 정보 검색 플랫폼

JAMA Internal Medicine

Volumn 173, Issue 8, 2013, Pages 671-672

Biomarkers in cardiovascular medicine: The shame of publication bias

(1) Nissen, Steven E a

a LERNER RESEARCH INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR PROCEDURE; CARDIOVASCULAR RISK; EVIDENCE BASED MEDICINE; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; NOTE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; PUBLICATION BIAS;

EID: 84876782593 PISSN: 21686106 EISSN: None Source Type: Journal
DOI: 10.1001/jamainternmed.2013.4074 Document Type: Note

Times cited : (7)

References (8)

1
- 0030027092
- Evidence based medicine: What it is and what it isn't
- Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ. 1996;312(7023):71-72.
- (1996) BMJ , vol.312 , Issue.7023 , pp. 71-72
- Sackett, D.L.¹ Rosenberg, W.M.² Gray, J.A.³ Haynes, R.B.⁴ Richardson, W.S.⁵

2
- 33746341926
- The file drawer problem and tolerance for null results
- doi:10.1037/0033-2909.86.3.638
- Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull. 1979;86(3):638-641. doi:10.1037/0033-2909.86.3.638.
- (1979) Psychol Bull. , vol.86 , Issue.3 , pp. 638-641
- Rosenthal, R.¹

3
- 38349049478
- Selective publication of antidepressant trials and its influence on apparent efficacy
- Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260.
- (2008) N Engl J Med. , vol.358 , Issue.3 , pp. 252-260
- Turner, E.H.¹ Matthews, A.M.² Linardatos, E.³ Tell, R.A.⁴ Rosenthal, R.⁵

4
- 34250212715
- Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
- Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl JMed. 2007;356(24):2457-2471.
- (2007) N Engl JMed. , vol.356 , Issue.24 , pp. 2457-2471
- Nissen, S.E.¹ Wolski, K.²

5
- 84876786998
- US National Institutes of Health. FDAAA 801 requirements. ClinicalTrials. gov. Updated December 2012. Accessed January 27, 2013
- US National Institutes of Health. FDAAA 801 requirements. ClinicalTrials. gov. http://clinicaltrials.gov/ct2/manage-recs/fdaaa. Updated December 2012. Accessed January 27, 2013.

6
- 84876785828
- Bias in associations of emerging biomarkers with cardiovascular disease [published online March 25,2013]
- Tzoulaki I, Siontis KC, Evangelou E, Ioannidis JPA. Bias in associations of emerging biomarkers with cardiovascular disease [published online March 25, 2013]. JAMA Intern Med. 2013;173(8):664-671.
- (2013) JAMA Intern Med. , vol.173 , Issue.8 , pp. 664-671
- Tzoulaki, I.¹ Siontis, K.C.² Evangelou, E.³ Ioannidis, J.P.A.⁴

7
- 33645960702
- Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio, and coronary heart disease: A literature-based meta-analysis of prospective studies
- Thompson A, Danesh J. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio, and coronary heart disease: A literature-based meta-analysis of prospective studies. J Intern Med. 2006;259(5):481-492.
- (2006) J Intern Med. , vol.259 , Issue.5 , pp. 481-492
- Thompson, A.¹ Danesh, J.²

8
- 34347378301
- Clinical trial registration: Looking back and moving ahead
- Laine C, Horton R, DeAngelis CD, et al. Clinical trial registration: Looking back and moving ahead. JAMA. 2007;298(1):93-94.
- (2007) JAMA , vol.298 , Issue.1 , pp. 93-94
- Laine, C.¹ Horton, R.² DeAngelis, C.D.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.